KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Consolidated Net Income (2009 - 2026)

Johnson & Johnson recorded quarterly Consolidated Net Income of $5.2 billion in Q1 2026, up 2.33% quarter-over-quarter from $5.1 billion in Q4 2025, and down 52.4% year-over-year from $11.0 billion in Q1 2025.

Johnson & Johnson's Consolidated Net Income history runs 17 years deep, the most recent figure standing at $5.2 billion for Q1 2026.

  • In Q1 2026, Consolidated Net Income fell 52.4% year-over-year to $5.2 billion; the TTM figure through Mar 2026 stood at $21.0 billion (up 91.29% YoY), while the FY2023 annual figure was $21.8 billion, up 1289.37% from the prior year.
  • Consolidated Net Income came in at $5.2 billion for Q1 2026 at Johnson & Johnson, up from $5.1 billion in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $21.7 billion in Q4 2023 to a low of -$232.0 million in Q3 2023.
  • A 4-year average of $4.3 billion and a median of $578.0 million in 2022 frame the typical range for Consolidated Net Income.
  • On a YoY basis, Consolidated Net Income climbed as much as 14575.0% in 2023 and fell as far as 142.03% in 2023.
  • Johnson & Johnson's Consolidated Net Income stood at $148.0 million in 2022, then tumbled by 156.08% to -$83.0 million in 2023, then surged by 6263.86% to $5.1 billion in 2025, then increased by 2.33% to $5.2 billion in 2026.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered $5.2 billion, $5.1 billion, and $5.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 7.40 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 5.24 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 697.00 Mn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -4.21 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 2.02 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -13.00 Mn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 2.68 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 31, 2023 -83.00 Mn
Oct 1, 2023 21.72 Bn
Jul 2, 2023 -232.00 Mn
Apr 2, 2023 423.00 Mn
Jan 1, 2023 293.00 Mn
Oct 2, 2022 148.00 Mn
Jul 3, 2022 552.00 Mn
Apr 3, 2022 578.00 Mn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn
Apr 4, 2021 6.20 Bn
Jan 3, 2021 1.74 Bn
Sep 27, 2020 3.55 Bn
Jun 28, 2020 3.63 Bn
Mar 29, 2020 5.80 Bn
Dec 29, 2019 4.01 Bn
Sep 29, 2019 1.75 Bn
Jun 30, 2019 5.61 Bn
Mar 31, 2019 3.75 Bn
Dec 30, 2018 3.04 Bn
Sep 30, 2018 3.93 Bn
Jul 1, 2018 3.95 Bn
Apr 1, 2018 4.37 Bn
Dec 31, 2017 -10.71 Bn
Oct 1, 2017 3.76 Bn
Jul 2, 2017 3.83 Bn
Apr 2, 2017 4.42 Bn
Jan 1, 2017 4.31 Bn
Oct 2, 2016 4.27 Bn
Jul 3, 2016 4.00 Bn
Apr 3, 2016 4.46 Bn
Jan 3, 2016 3.76 Bn
Sep 27, 2015 3.36 Bn
Jun 28, 2015 4.52 Bn
Mar 29, 2015 4.32 Bn
Dec 28, 2014 2.52 Bn
Sep 28, 2014 4.75 Bn
Jun 29, 2014 4.33 Bn
Mar 30, 2014 4.73 Bn
Dec 29, 2013 3.52 Bn
Sep 29, 2013 2.98 Bn
Jun 30, 2013 3.83 Bn
Mar 31, 2013 3.50 Bn
Dec 30, 2012 2.57 Bn
Sep 30, 2012 2.63 Bn
Jul 1, 2012 1.41 Bn
Apr 1, 2012 3.91 Bn
Jan 1, 2012 956.00 Mn
Oct 2, 2011 3.20 Bn
Jul 3, 2011 2.78 Bn
Apr 3, 2011 3.48 Bn
Jan 2, 2011 2.23 Bn
Oct 3, 2010 3.42 Bn
Jul 4, 2010 3.45 Bn
Apr 4, 2010 4.53 Bn
Jan 3, 2010 2.21 Bn
Sep 27, 2009 3.35 Bn
Jun 28, 2009 3.21 Bn
Mar 29, 2009 3.51 Bn